Skip to content

Active ingredient

Liraglutide

21 finished FDA listings contain Liraglutide as their only active ingredient; 1 combination products also contain it.

FDA NDC Directory

Ingredient names as written by FDA
LIRAGLUTIDE
Dosage forms
Injection, Injection, Solution
Routes
Subcutaneous
Manufacturers / labelers
13
Strengths listed
18 mg/3ml · 6 mg/ml
Brand names in FDA listings
Saxenda, Victoza

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 475968

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 022341NOVO NORDISK INC2010-01-255
NDA 206321NOVO2014-12-232
ANDA 215503HIKMA2024-12-234
ANDA 218115NANJING KING FRIEND2025-04-022
ANDA 215421LUPIN2025-07-221
ANDA 214568TEVA PHARMS2025-08-271
ANDA 217590ORBICULAR2026-01-142
ANDA 217234ORBICULAR2026-02-242
ANDA 217063BIOCON PHARMA2026-02-241
ANDA 215245BIOCON PHARMA2026-03-111

Official labeling on DailyMed

Showing the 12 most recent of 21 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.